Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer

Journal of Oncology Practice

Volumn 9, Issue 6 SUPPL., 2013, Pages

  Zullig, Leah L ^a,b,c,d,e,f   Peppercorn, Jeffrey M ^a,b,c,d,e,f   Schrag, Deborah ^a,b,c,d,e,f   Taylor Jr , Donald H ^a,b,c,d,e,f   Lu, Ying ^a,b,c,d,e,f   Samsa, Gregory ^a,b,c,d,e,f   Abernethy, Amy P ^a,b,c,d,e,f   Zafar, S Yousuf ^a,b,c,d,e,f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE CANCER INSTITUTE   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; BASIC NEEDS; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; COPING BEHAVIOR; DISTRESS SYNDROME; DRUG COST; FEMALE; FINANCIAL MANAGEMENT; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTION; SOLID TUMOR; TREATMENT REFUSAL;

EID: 84897064226     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.000971     Document Type: Article

References (12)

1. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103: 117-28
2. Soni A: Top 10 most costly conditions among men and women, 2008: Estimates for the U.S. civilian noninstitutionalized adult population, age 18 and older. http://meps.ahrq.gov/mepsweb/data-files/publications/st331/stat331. shtml
3. The Henry J. Kaiser Family Foundation: Distribution of covered workers facing different cost-sharing formulas for prescription drug benefits, 2000-2012 (Exhibit 9.2). http://kff.org/report-section/ehbs-2012-section-9/
4. The Henry J. Kaiser Family Foundation and Health Research & Trust: Employer health benefits, 2011 annual survey. http://familiesusa2.org/ conference/health-action-2012/toolkit/content/pdfs/EHB.pdf
5. Bernard DS, Farr SL, Fang Z: National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29:2821-2826, 2011
6. Rajurkar SP, Presant CA, Bosserman LD, et al: A copay foundation assistance support program for patients receiving intravenous cancer therapy. J Oncol Pract 7:100-102, 2011
7. Schoen C, Doty MM, Robertson RH, et al: Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent. Health Aff (Millwood) 30:1762-1771, 2011
8. Neugut AI, Subar M, Wilde ET, et al: Association between prescription copayment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29:2534-2542, 2011
9. Streeter SB, Schwartzberg L, Husain N, et al: Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract 7: 46s-51s, 2011 (suppl 3)
10. Hershman DL, Shao T, Kushi LH, et al: Early discontinuation and nonadherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126: 529-537, 2011
11. Schrag D, Naughton M, Kesselheim A, et al: Clinical trial participants' strategies for coping with prescription drug costs: A companion study to CALGB 80405. J Clin Oncol 27:483s, 2009 (suppl 15s; abstr 9503)
12. Felder TM, Lal LS, Bennett CL, et al: Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center. Community Oncol 8:279-286, 2011